{"podcast":{"title":"Blunt Business","slug":"blunt-business-326858","podcast_index_feed_id":326858,"rss_url":"https://feeds.redcircle.com/6370efa4-01ee-4341-adc8-94112a86e8e5","website_url":"https://redcircle.com/shows/blunt-business1131","image_url":"https://media.redcircle.com/images/2026/1/7/5/83efac08-c3e8-48ab-99a9-2ed18dfcdf15_blunt_business_logo_2026.jpg","author":"Cannabis Radio","episode_count":473,"summary":"Dispensing Cannabis business knowledge beyond a million square feet of cultivation space. Blunt Business will navigate the challenges and opportunities of one of the most profitable industries on earth. Join us each episode to hear our weekly round tables and interviews with industry professionals.","last_synced_at":"2026-06-24T14:20:39.709364+00:00","page_url":"https://stenobird.com/podcast/blunt-business-326858"},"episode":{"title":"Clarifying Cannabis From THCA Loopholes to Schedule III Shifts","slug":"clarifying-cannabis-from-thca-loopholes-to-schedule-iii-shifts","published_at":"2026-06-17T05:24:27+00:00","page_url":"https://stenobird.com/podcast/blunt-business-326858/clarifying-cannabis-from-thca-loopholes-to-schedule-iii-shifts","show_page_url":"https://stenobird.com/podcast/blunt-business-326858","url":"https://cannabisradio.com/audio/7919","audio_url":"https://audio3.redcircle.com/episodes/0519af63-4a23-4058-8ee5-30ca33062f1e/stream.mp3","summary":"Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors. She clarifies the critical distinction between THCA—the non-intoxicating precursor that converts to THC upon heating—and delta-9 THC, noting that current marketing often masks the potential intoxicating effects of heated THCA products. Dr. Sharma also unpacks the implications of the Schedule III reclassification, explaining why it creates a distinct \"two-lane system\" for medical cannabis versus industrial hemp rather than a blanket regulatory change. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy","meta_description":"Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis an…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2452,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blunt-business-326858/episodes/clarifying-cannabis-from-thca-loopholes-to-schedule-iii-shifts/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blunt-business-326858/clarifying-cannabis-from-thca-loopholes-to-schedule-iii-shifts.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}